01 1Unimark Remedies
01 1TOPIRAMATE USP (PROCESS A)
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-02-21
Pay. Date : 2013-07-24
DMF Number : 23349
Submission : 2009-11-30
Status : Active
Type : II
20
Unimark Remedies Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TOPIRAMATE USP (PROCESS A), with a corresponding US DMF Number 23349.
Remarkably, this DMF maintains an Active status since its submission on November 30, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 21, 2014, and payment made on July 24, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
